NCT04354779View on ClinicalTrials.gov

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

CompletedOBSERVATIONAL
Enrollment

3,301

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

August 23, 2020

Study Completion Date

September 28, 2020

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2SARS-CoV 2Coronavirus InfectionCovid19
Interventions
DIAGNOSTIC_TEST

a specifically designed self-administered questionnaire

The questionnaire consists of the following items: questions related to personal health, traveling activities, living situation, as well as inquiries of symptoms and comorbidities.

Trial Locations (1)

1200

Allgemeine Unfallversicherungsanstalt, Vienna

All Listed Sponsors
collaborator

Paracelsus Medical University

OTHER

lead

AUVA

OTHER

NCT04354779 - Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | Biotech Hunter | Biotech Hunter